Approval · Notice of Compliance 14904 · 2013
RAN-OXYCODONE CR: Notice of Compliance 14904
Issued November 15, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14904
- Date
- November 15, 2013
- Company
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Opioid analgesic
- Canadian reference product
- OXYCONTIN (Purdue Pharma)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAN-OXYCODONE CR | 02416352 | Cancelled Pre Market |
| RAN-OXYCODONE CR | 02416360 | Cancelled Pre Market |
| RAN-OXYCODONE CR | 02416379 | Cancelled Pre Market |
Medicinal ingredients
- OXYCODONE HYDROCHLORIDE 40 MG per TAB
- OXYCODONE HYDROCHLORIDE 60 MG per TAB
- OXYCODONE HYDROCHLORIDE 80 MG per TAB